A-to-G/C/T and C-to-T/G/A dual-function base editor for creating multi-nucleotide variants.

J Genet Genomics

Department of Obstetrics and Gynecology, Guangdong Provincial Key Laboratory of Major Obstetric Diseases, Guangdong Provincial Clinical Research Center for Obstetrics and Gynecology, Guangdong-Hong Kong-Macao Greater Bay Area Higher Education Joint Laboratory of Maternal-Fetal Medicine, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510150, China. Electronic address:

Published: December 2024

Multi-nucleotide variants (MNVs) are critical genetic variants associated with various genetic diseases. However, tools for precisely installing MNVs are limited. In this study, we present the development of a dual-base editor, BDBE, by integrating TadA-dual and engineered human N-methylpurine DNA glycosylase (eMPG) into nCas9 (D10A). Our results demonstrate that BDBE effectively converts A-to-G/C/T (referred to as A-to-B) and C-to-T/G/A (referred to as C-to-D) simultaneously, yielding nine types of dinucleotides from adjacent CA nucleotides while maintaining minimal off-target effects. Notably, BDBE4 exhibits exceptional performance across multiple human cell lines and successfully simulated all nine dinucleotide MNVs from the gnomAD database. These findings indicate that BDBE significantly expands the product range of base editors and offers a valuable resource for advancing MNV research.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jgg.2024.10.001DOI Listing

Publication Analysis

Top Keywords

multi-nucleotide variants
8
a-to-g/c/t c-to-t/g/a
4
c-to-t/g/a dual-function
4
dual-function base
4
base editor
4
editor creating
4
creating multi-nucleotide
4
variants multi-nucleotide
4
variants mnvs
4
mnvs critical
4

Similar Publications

A-to-G/C/T and C-to-T/G/A dual-function base editor for creating multi-nucleotide variants.

J Genet Genomics

December 2024

Department of Obstetrics and Gynecology, Guangdong Provincial Key Laboratory of Major Obstetric Diseases, Guangdong Provincial Clinical Research Center for Obstetrics and Gynecology, Guangdong-Hong Kong-Macao Greater Bay Area Higher Education Joint Laboratory of Maternal-Fetal Medicine, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510150, China. Electronic address:

Multi-nucleotide variants (MNVs) are critical genetic variants associated with various genetic diseases. However, tools for precisely installing MNVs are limited. In this study, we present the development of a dual-base editor, BDBE, by integrating TadA-dual and engineered human N-methylpurine DNA glycosylase (eMPG) into nCas9 (D10A).

View Article and Find Full Text PDF

The identification of anticancer therapies using next-generation sequencing (NGS) is necessary for the treatment of cholangiocarcinoma. NGS can be easily performed when cell blocks (CB) are obtained from bile stored overnight. We compared NGS results of paired CB and surgically resected specimens (SRS) from the same cholangiocarcinoma cases.

View Article and Find Full Text PDF

Allelic variation at the Ptprc gene, which encodes the pan-leukocyte marker CD45/Ly5, is commonly exploited to track hematopoietic reconstitution by flow cytometry in mixed bone marrow chimera transplant experiments. Historically, this was accomplished using bone marrow from C57BL/6 (Ptprc/CD45.2/Ly5.

View Article and Find Full Text PDF

DNA Checkpoint Gene Mutation as a Biomarker for Immune Checkpoint Inhibitor Therapy in Advanced Biliary Tract Cancer.

Anticancer Res

May 2024

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea

Article Synopsis
  • The study investigates the role of the DNA checkpoint (DNACHK) pathway in cancer immunotherapy, focusing on its effects on patients with advanced biliary tract cancers treated with immune checkpoint inhibitors (ICIs).
  • A total of 62 patients were analyzed, with 40.3% having mutations in the DNACHK pathway, while the remaining were wild-type; key mutations included alterations in genes like ATM and TP53BP1.
  • Results suggest that patients with DNACHK mutations had a slightly better disease control rate and overall survival compared to the wild-type group, indicating the potential of DNACHK as a biomarker for ICI response.
View Article and Find Full Text PDF

Penetrance, variable expressivity and monogenic neurodevelopmental disorders.

Eur J Med Genet

June 2024

Nantes Université, CHU Nantes, Service de Génétique Médicale, 44000, Nantes, France; Nantes Université, CHU Nantes, CNRS, INSERM, L'institut Du Thorax, 44000 Nantes, France. Electronic address:

Article Synopsis
  • The study investigates the concept of incomplete penetrance in neurodevelopmental disorders, where some individuals carry pathogenic genetic variants but remain asymptomatic.
  • Between 2020 and 2022, researchers collaborated with a French network to analyze families where affected individuals had inherited these variants from symptom-free parents, finding 12 cases with significant genetic findings.
  • The results suggest that incomplete penetrance may be more common than previously acknowledged, highlighting its importance for genetic interpretation, counseling, and future research into its underlying mechanisms.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!